Who was studied?
40 patients at Jiangyin Hospital Affiliated to Nantong University; 39 had at least one assessment of non-irradiated lesions.
What does the publication report?
Reported ORR was 30.8% and DCR 71.8% in the evaluable population.
Safety findings
28 patients (70.0%) had treatment-related adverse events; 4 (10%) had grade ≥3 events.
How should we interpret it?
Single-center, single-arm evidence. Potential overlap with multicenter reports cannot be resolved from the abstract and patient totals should not be pooled.
Read the original source
This independently written summary was checked against the publicly available abstract. Selected figures, where included, are checked against the full publication. This is not a full-paper translation or a clinical recommendation.
Clinical efficacy of hypofractionated radiotherapy combined with immune checkpoint inhibitors in advanced metastatic solid tumors
Educational reporting, not individualized medical advice. Discuss treatment decisions with your clinical team.